Krystal Biotech, Inc. / Fundamentals
Income statement
- Net revenue
€308.20M - Cost of goods sold
€14.30M - Gross profit
€286.43M - SG&A expenses
€109.72M - R&D expenses
€47.79M - EBITDA
€129.82M - D&A
€4.08M - EBIT
€119.52M - Interest expenses
€0.00 - EBT
€144.79M - Tax expenses
€4.41M - Net income
€125.89M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€20.89M - Changes in working capital
€10.76M - Operating cash flow
€167.65M - Capex
€8.54M - Other investing cash flow
€373.23K - Net investing cash flow
-€157.36M - Total cash dividends paid
€0.00 - Issuance of common stock
€2.89M - Debt repayment
€0.00 - Other financing cash flow
-€4.18M - Net financing cash flow
-€4.18M - Foreign exchange effects
€791.08K - Net change in cash
€6.90M - Cash at end of period
€303.59M - Free cash flow
€176.19M
Balance sheet
- Cash and cash equivalents
€303.59M - Cash and short-term investments
€585.14M - Total receivables
€95.61M - Inventory
€26.63M - Other current assets
€14.48M - Total current assets
€721.88M - Property, plant & equipment
€135.60M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€119.10M - Other non-current assets
€169.03K - Total non-current assets
€254.87M - Total assets
€976.74M - Accounts payable
€6.11M - Short-term debt
€1.39M - Other current liabilities
€71.44M - Total current liabilities
€74.56M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€9.31M - Total non-current liabilities
€9.31M - Total liabilities
€83.87M - Common stock
€0.00 - Retained earnings
-€91.46M - Other equity
€992.71K - Total equity
€892.88M - Total liabilities and shareholders' equity
€976.74M
Company information
- Market capitalization
€3.42B - Employees
275 - Enterprise Value
€3.74B
Company ratios
- Gross margin
-
92.9% Much better than peer group: -52,888.4% - EBITDA margin
-
42.1% Much better than peer group: -74,511.0% - EBIT margin
-
38.8% Much better than peer group: -75,054.4% - EBT margin
-
47.0% Much better than peer group: -72,668.8% - Net margin
-
40.8% Much better than peer group: -73,274.3% - ROE
-
14.1% Much better than peer group: -67.6% - ROA
-
12.9% Much better than peer group: -91.1% - Asset turnover
-
31.6% Better than peer group: 15.4% - FCF margin
-
51.6% Much better than peer group: -67,945.6% - FCF yield
4.6% - Efficiency ratio
57.9% - Net sales per employee
-
€1.12M - Net income per employee
-
€457.78K